Chronic Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology
Cover of the book Chronic Myeloid Leukemia by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319331980
Publisher: Springer International Publishing Publication: August 17, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319331980
Publisher: Springer International Publishing
Publication: August 17, 2016
Imprint: Springer
Language: English

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

More books from Springer International Publishing

Cover of the book Cardiac Regeneration by
Cover of the book Privacy-Enhancing Aggregation Techniques for Smart Grid Communications by
Cover of the book Rare Genitourinary Tumors by
Cover of the book Assisting Young Children Caught in Disasters by
Cover of the book Mobile Solutions and Their Usefulness in Everyday Life by
Cover of the book Hardware Accelerators in Data Centers by
Cover of the book Sea Ports and Sea Power by
Cover of the book Systems for Drug Delivery by
Cover of the book Beyond Databases, Architectures and Structures. Facing the Challenges of Data Proliferation and Growing Variety by
Cover of the book Smart Grids from a Global Perspective by
Cover of the book Mechanism, Machine, Robotics and Mechatronics Sciences by
Cover of the book War and Memory in Russia, Ukraine and Belarus by
Cover of the book The Myth of Mao Zedong and Modern Insurgency by
Cover of the book The Essence of Turbulence as a Physical Phenomenon by
Cover of the book Advances in Through-life Engineering Services by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy